Academic Journal

Comparison of the Incidence and Magnitude of Hyponatremia Among Patients With Poststroke Depression Receiving Either Escitalopram or Sertraline

التفاصيل البيبلوغرافية
العنوان: Comparison of the Incidence and Magnitude of Hyponatremia Among Patients With Poststroke Depression Receiving Either Escitalopram or Sertraline
المؤلفون: Lina Naseralallah, Zahra Noureddine, Somaya Koryash
المصدر: Pharmacology Research & Perspectives, Vol 12, Iss 6, Pp n/a-n/a (2024)
بيانات النشر: Wiley, 2024.
سنة النشر: 2024
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: adverse drug reactions, depression, hyponatremia, poststroke depression, selective serotonin reuptake inhibitors, stroke, Therapeutics. Pharmacology, RM1-950
الوصف: ABSTRACT Depression is the most frequent psychiatric condition experienced in stroke survivors. Selective serotonin reuptake inhibitors (SSRIs) are frequently used as first‐line antidepressants; however, they have been strongly associated with hyponatremia which, in poststroke patients, can worsen outcomes. This study aims to determine and compare the incidence and magnitude of hyponatremia and potential risk factors in patients receiving either escitalopram or sertraline for the management of poststroke depression (PSD). A retrospective observational study involving all hospitalized patients who received either escitalopram or sertraline for the treatment of PSD. Electronic medical records were reviewed over a 5‐year period with data collected on various demographic, laboratory, comorbidity, and medication‐related variables. Data were analyzed using multivariate logistic regression. A total of 401 patients met the inclusion criteria. Overall, 36.7% of patients experienced hyponatremia, with 67 (38.3%) cases in patients receiving escitalopram and 76 (33.6%) in sertraline group. The median drop in sodium level from baseline was 5 mmol/L in both groups; with the majority of cases being of mild nature (73.1% and 69.7% for escitalopram and sertraline, respectively). Findings from the multivariate logistic regression did not yield a model with significant association (p = 0.353). Escitalopram and sertraline were both associated with an increased risk of hyponatremia in poststroke patients, with most cases being mild. There was no significant difference between treatment arms regarding the incidence or magnitude of hyponatremia. Caution should be exercised when prescribing escitalopram or sertraline.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2052-1707
Relation: https://doaj.org/toc/2052-1707
DOI: 10.1002/prp2.70041
URL الوصول: https://doaj.org/article/04110146d33b4ba2a570f2fe3c21fbe9
رقم الانضمام: edsdoj.04110146d33b4ba2a570f2fe3c21fbe9
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20521707
DOI:10.1002/prp2.70041